BVS Bioventus Inc.

12.77USD-2.52%Mkt Cap: 872.26M $P/E: 16.37

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which compr…

Key Statistics

Company
Market Cap872.26M USD
Enterprise Value1.18B USD
Revenue (TTM)581.85M USD
Gross Profit388.16M USD
Net Income (TTM)22.73M USD
Revenue/Share8.65 USD
Last Price12.77 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees950
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)16.37
P/E (Forward)14.24
PEG1.53
EV/EBITDA14.69
EV/Revenue2.02
P/S1.54
P/B3.91
EPS (TTM)0.78
EPS (Forward)0.92
52W Range
6.25568% of range15.89
52W High15.89 USD
52W Low6.255 USD
Profitability
Gross Margin68.33%
Oper. Margin12.23%
EBITDA Margin13.77%
Profit Margin4.00%
ROE12.35%
ROA3.33%
Growth
Revenue Growth3.80%
Earnings Growth327.30%
Cash Flow & Leverage
Operating CF74.67M USD
CapEx (TTM)2.56M USD
FCF Margin11.65%
FCF Yield7.77%
Net Debt233.35M USD
Net Debt/EBITDA2.91
Balance Sheet
Debt/Equity1.60
Current Ratio1.69
Quick Ratio1.11
Book Value/Sh3.35 USD
Cash/Share0.45 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)17.60 USD
Upside (mean)+37.8%
Target Range15.00 USD – 19.00 USD
15.00+37.8% to mean19.00
# Analysts5
Ownership
Shares Out.68.31M
Float34.30M
Insiders11.65%
Institutions84.69%
Short Interest
Short Ratio5.4d
Short % Float6.25%
Short % Out.4.29%
Shares Short2.93M
Short (prev mo.)2.33M
Technical
SMA 5013.69 (-6.7%)
SMA 20010.31 (+23.9%)
Beta0.64
S&P 52W Chg16.45%
Avg Vol (30d)499.87K
Avg Vol (10d)427.31K
Technical Indicators
RSI (14)40.9
MACD-0.0609
MACD Signal0.0371
MACD Hist.-0.0980
BB Upper14.15 USD
BB Middle13.40 USD
BB Lower12.66 USD
BB Width11.16%
ATR (14)0.5152 USD
Vol Ratio (20d)0.80x